TLR4 and Sepsis: One previous study showed that simvastatin improved endothelial permeability and mitigated sepsis-induced ALI, oxidative stress, and apoptosis by inhibiting the Bax, caspase-3, and toll-like receptor 4 (TLR4)/NF-kB signaling pathway [15].